The Ignatius laboratory is interested in understanding the effects of
tumor heterogeneity on relapse and resistance to therapies in Rhabdomyosarcoma and other sarcomas.
Not exact matches
They did so by including factors like the mechanical forces acting
on the cells and the
tumor's cellular
heterogeneity.
With respect to biological applications, the group is focusing
on how cellular
heterogeneity and cell - to - cell communication drive ensemble - level decision - making in the immune system, with an emphasis
on «two - body» interaction (e.g., host cell - virus interactions, innate immune control of adaptive immunity,
tumor infiltration by immune cells).
More recently, he has focused
on triple - negative breast cancer, the role of micro-RNAs in cancer growth and metastasis,
tumor heterogeneity and novel approaches to targeting therapy - resistant breast cancers.
Discover novel treatments in relapsed pediatric cancer by defining
tumor heterogeneity and its effect
on self - renewal and metastasis.
A unique focus of my work is
on the impact of
heterogeneity within
tumors and
tumor cell populations, including subpopulations commonly referred to as «cancer stem cells»,
on the immune response.
Since
heterogeneity in the
tumor microenvironment, such as the presence of a neighboring blood vessel, may drive genetic changes, he reasoned that it might also be reflected
on the level of proteins.
Although many posit that
tumor cell
heterogeneity is of a genetic basis associated with inherent high genomic instability in
tumor cells, the heterogeneous cellular composition in
tumors has also been hypothesized, early
on, to be the consequence of abnormal
tumor stem cell differentiation (9).
To translate advances in our understanding of molecular mechanisms of oncogenesis and
tumor progression into novel therapeutic strategies.With primary focus
on lung cancer, melanoma, and lymphoma / leukemia, we will use the strength of in - depth molecular and phenotypic characterization of
tumor heterogeneity to identify new targets and translate those into new therapeutic opportunities.